Abstract
This study examines the effect of new 1,5 benzodiazepines on acetylcholinesterase (AChE) and ATPDase (apyrase) activities from cerebral cortex of adult rats. Simultaneously, the effects of the classical 1,4-benzodiazepine on these enzymes were also studied for comparative purpose. The compounds 2-trichloromethyl-4-phenyl-3H-1,5-benzodiazepin and 2-trichloromethyl-4-(p-methyl-phenyl)-3H-1,5-benzodiazepin significantly inhibited acetylcholinesterase activity (p < 0.01) when tested in the range of 0.18–0.35 mM. The inhibition caused by these two new benzodiazepines was noncompetitive in nature. Similarly, at concentrations ranging from 0.063 to 0.25 mM, the 1,5 benzodiazepines inhibited ATP and ADP hydrolysis by synaptosomes from cerebral cortex (p < 0.01). However, the inhibition of nucleotide hydrolysis was uncompetitive in nature. Our results suggest that, although diazepam and the new benzodiazepines have chemical differences, they both presented an inhibitory effect on acetylcholinesterase and ATPDase activities.
Similar content being viewed by others
REFERENCES
Richardson, P. J., and Brown, S. J. 1987. ATP release from affinity-purified rat cholinergic nerve terminals. J. Neurochem. 48:622–630.
Wess, J. 1993. Molecular basis of muscarinic acetylcholine receptor function. Trends Pharmacol. Sci. 14:308–313.
Buccafusco, J. J., and Brezenoff, H. E. 1986. Brain neurotransmitters and the development and maintenance of hypertension. Prog. Drug. Res. 30:127–150.
Lundberg, J. M. 1996. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol. Rev. 48:113–178.
Phillis, J. W., and Wu, P. H. 1981. The role of adenosine and its nucleotide in central synaptic transmission. Prog. Neurobiol. 16:187–239.
Silinski, E. M., Gerzanich, V., and Vanner, S. M. 1992. ATP mediates excitatory synaptic transmission in mammalian neurones. Br. J. Pharmacology 106:762–763.
Edwards, F. A., Gibb, A. J., and Colquhoun, D. 1992. ATP receptor-mediated synaptic currents in the central nervous system. Nature 359:144–147.
Schetinger, M. R. C., Bonan, C. D., Frasetto, S., Wyse, A. T., Schierholt, R. Webber, A, Dias, R. D., Sarkis, J. J. F., and Netto, C. A. 1999. Pre-conditioning to global ischemia changes hippocampal acetylcholinesterase in the rat. Biochem. Mol. Biol. Int. 47:473–478.
Schetinger, M. R. C., Bonan, C. D., Schierholt, R. C., Webber, A, Arteni, N., Emanuelli, T., Dias, R. D., Sarkis, J. J. F., and Netto, C. A 1998. Nucleotide Hydrolysis in rats submitted to global cerebral ischemia: a possible link between preconditioning and adenosine production. J. Stroke Cerebrovasc. Dis. 7:281–286.
Nagy, A. K. 1996. Ecto-ATPases-Recent Progress on Structure and Function. Pages 1–13, in Plesner, L., Kirley. T., and Knowles, F. (eds.), Ecto-ATPases of the nervous system. Plenum Press, New York.
Zimmermann, H., Grondal, E. J. M., and Keller, F. 1986. Cellular Biology of Ecto-Enzymes. Pages 35–48, in Kreutzberg, G. W., Reddington, M. and Zimmermann, H. (eds), Hydrolysis of ATP and formation of adenosine at the surface of cholinergic nerve endings. Springer-Verlag, Heidelberg, Berlin, New York, Tokyo.
Zimmermann, H. 1996. Biochemistry, localization and functional roles of ectonucleotidases in the nervous system. Prog. Neurobiol. 49:589–618.
Schetinger, M. R. C., Falquembach, F., Michelot, F., Mezzomo, A., and Rocha, J. B. T. 1998. Heparin modulates adenine nucleotide hydrolysis by synaptosomes from cerebral cortex. Neurochem. Int. 33:243–249.
Battastini, A. M. O., Rocha, J. B. T., Barcellos, C. K., Dias, R. D., and Sarkis, J. J. F. 1991. Characterization of an ATPDase (EC 3.6.1.5) in synaptosomes from cerebral cortex of adult rats. Neurochem. Res. 16:1303–1310.
Meyerhof, O. 1945. The origin of the reaction of Harden and Young in cell-free alcoholic fermentation. J. Biol. Chem. 157: 105–119.
Milatovic, D., and Dettbarn, W-D. 1996. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat. Toxicol. Appl. Pharmacol. 136:20–28.
Black, H. E., Szot, R. J., Arthaud L. E., Massa, T., Mylecraine, M., Klein, M., Lake, R., Fabry, A, Kaminska, G. Z., Sinha, D. P., and Schwartz, E. 1987. Preclinical safety evaluation of the benzodiazepine quazepam. Arzneim.-Forsch.(Drug Res). 37: 906–913.
Owen, G., Smith, T. H. F., and Agersborg Jr. H. P. K. 1970. Toxicity of some benzodiazepine compounds with CNS activity. Toxicol. Appl. Pharmacol. 16:556–570.
Braestrup, C., and Squires, R. F. 1977. Specific benzodiazepine receptor in the brain characterized by high affinity [3H]diazepam binding. Proc. Natl. Acad. Sci. USA 74:3805–3809.
Barnard, E. A., Skolnick, R., Olsen, R. W., Mohler, H., Sieghart, W., Biggio, G., Braestrup, C., Bateson, A. N., and Langer, S. Z. 1998. International union of pharmacology. XV. Subtypes of ?-aminobutyric acid receptors: Classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50: 291–313.
Davis, K. L., and Mohs, R. C. 1982. Enhancement of memory process in Alzheimer's disease with multiple-dose intravenous physostigmine. Am. J. Psychiatry, 139:1421–1424.
Miyamoto, M., Takahashi, H., Kato, K., Hirai, K., Ishihara, Y., and Goto, G. 1996. Effects of 3-[1-(Phenylmethyl)-4-Piperidinyl]-1(2,3,4,5-Tetrahydro-1H-1-Benzazepin-8-yl)-1-Propanone Fumarate (TAK-147), a novel acetylcholinesterase inhibitor, on impaired learning and memory in animal models. J. Pharmacol. Exp. Ther. 277:1292–1304.
Burns A, Russel, E., and Page, S. 1999. New drugs for Alzheimer's Disease. Br. J. Psychiatry, 174:476–479.
Bonan, C. D., Battastini, A. M. O., Schetinger, M. R. C., Moreira, C. M., Frasetto, S., Dias, R. D., and J. J. F. Sarkis. 1997. Effects of 9-amino-1,2,3,4-tetrahydroacridine (THA) on ATPDase (EC 3.6.1.5) and 5?-nucleotidase (EC 3.1.3.5) from rat brain synaptosomes. Gen. Pharmacol. 26:761–766.
Barcellos, C. K., Schetinger, M. R. C., Dias, R. D., and Sarkis, J. J. F. 1998. In vitro effect of central nervous system active drugs on the ATPase-ADPase activity and acetylcholinesterase activity from cerebral cortex of adult rats. Gen. Pharmacol. 31:563–567.
Bonacorso, H. G., Bittencourt, S. T., Wastowski, A. D., Wentz, A. P., Zanatta, N., and Martins, M. A. 1996. A convenient method for the synthesis of 2-trichloromethyl-4-p-substitutedphenyl-3H-1,5-benzodiazepines. Tetrahedron Letters 37:9155–9156.
Ellman, G. L. Courtney, K. D., Andres Jr. V., and Featherstone, R. M. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:88–95.
Villescas, R., Ostwald, R., Morimoto, H., and Bennet, E. 1981. Effects of neonatal undernutrition and cold stress on behavior and biochemical brain parameters in rats. J. Nutr., 11:1103–1110.
Nagy, A., and Delgado-Escueta, A. V. 1984. Rapid preparation of synaptosomes from mammalian brain using a nontoxic isosmotic gradient (Percoll). J. Neurochem., 43:1114–1123.
Chan, K., Delfert, D., and Junger, K. D. 1986. A direct colorimetric assay for Ca2+ ATPase activity. Anal. Biochem., 157: 375–380.
Bradford, M. M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72:248–254.
Dixon, M., and Webb, E. C. 1964. Enzymes, 2nd ed. p.950. Longmans, London.
Cornish-Bowden, A. 1974. A simple graphical method for determinating the inhibition constant of mixed, uncompetitive and non-competitive inhibitors. Biochem. J. 137:143–144.
Dowd, J., E. and Riggs, D., S. 1965. A comparison of estimaties of Michaelis-Menten kinetic constants from various linear transformations. J. Biol. Chem. 240:863–869.
Role, L. W., and Berg, D. K. 1996. Nicotinic receptors in the development and modulation of CNS synapses. Neuron, 16: 1077–1085.
Evans, R. J., Derkach, V., and Surprenant, A. 1992. ATP mediates fast synaptic transmission in mammalian neurons. Nature, 359:144–147.
Kegel, B., Braun, N., Heine, P., Maliszewski, C. R. and Zimmermann, H. 1997. An ecto-ATPase and nan ecto-ATP diphosphohydrolase are expressed in rat brain. Neuropharmacol. 36:1189–1200.
Szegletes, T., Mallander, W. D., Thomas, P. J., and Rosenberry, T. L. 1999. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate Inhibition arises as a secondary effect. Biochemistry 38:122–133.
Wilson, I. B. 1957. Specificity in cholinesterase reactions. Pages 175–185, in Pauling, L., and Itano, H. (eds.), Acetylcholines-terase: Molecular Structure and Biological Specificity, American Institute of Biological Sciences, New York.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schetinger, M.R.C., Porto, N.M., Moretto, M.B. et al. New Benzodiazepines Alter Acetylcholinesterase and ATPDase Activities. Neurochem Res 25, 949–955 (2000). https://doi.org/10.1023/A:1007500424392
Issue Date:
DOI: https://doi.org/10.1023/A:1007500424392